Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Rapport Therapeutics, Inc. (RAPP) had Weighted-Average Shares Outstanding (Diluted) of 20.74M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-78.31M |
|
-- |
|
-- |
|
$83.06M |
|
$-83.06M |
|
$4.75M |
|
$-78.31M |
|
$-78.31M |
|
$-78.31M |
|
$-78.31M |
|
$-78.31M |
|
$-78.31M |
|
$-83.06M |
|
$-85.43M |
|
20.74M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
20.74M |
$-3.78 |
|
$-3.78 |
|
| Balance Sheet Financials | |
$309.80M |
|
$3.53M |
|
$5.13M |
|
$314.93M |
|
$8.77M |
|
-- |
|
$0.74M |
|
$9.51M |
|
$305.43M |
|
$305.43M |
|
$305.43M |
|
36.58M |
|
| Cash Flow Statement Financials | |
$-64.83M |
|
$-170.14M |
|
$221.62M |
|
$70.25M |
|
$56.91M |
|
$-13.34M |
|
$10.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
35.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-67.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.64% |
|
-25.64% |
|
-24.86% |
|
-25.64% |
|
$8.35 |
|
$-3.24 |
|
$-3.13 |
|